4//SEC Filing
Hingtgen Tim 4
Accession 0000950170-25-031118
CIK 0001108109other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:06 PM ET
Size
30.1 KB
Accession
0000950170-25-031118
Insider Transaction Report
Form 4
Hingtgen Tim
Division President
Transactions
- Exercise/Conversion
Performance Based Restricted
2025-03-01−33,600→ 166,400 totalExercise: $0.00→ Common Stock (33,600 underlying) - Disposition to Issuer
Performance Based Restricted
2025-03-01−166,400→ 0 totalExercise: $0.00→ Common Stock (166,400 underlying) - Exercise/Conversion
Common Stock
2025-03-01+33,600→ 1,267,588 total - Award
Common Stock
2025-03-01+200,000→ 1,467,588 total - Award
Stock Options (Right to Buy)
2025-03-01+200,000→ 200,000 totalExercise: $3.01From: 2026-03-01Exp: 2035-02-28→ Common Stock (200,000 underlying) - Award
Performance Based Restricted
2025-03-01+400,000→ 400,000 totalExercise: $0.00→ Common Stock (400,000 underlying) - Tax Payment
Common Stock
2025-03-01$3.01/sh−78,807$237,209→ 1,388,781 total
Holdings
- 200,000
Stock Options (Right to Buy)
Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (200,000 underlying) - 100,000
Stock Options (Right to Buy)
Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (100,000 underlying) - 200,000
Stock Options (Right to Buy)
Exercise: $2.87From: 2025-03-01Exp: 2034-02-28→ Common Stock (200,000 underlying) - 56,250
Stock Options (Right to Buy)
Exercise: $4.99From: 2020-03-01Exp: 2029-02-28→ Common Stock (56,250 underlying) - 75,000
Stock Options (Right to Buy)
Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (75,000 underlying) - 100,000
Stock Options (Right to Buy)
Exercise: $8.81From: 2022-03-01Exp: 2031-02-28→ Common Stock (100,000 underlying) - 200,000
Stock Options (Right to Buy)
Exercise: $6.15From: 2024-03-01Exp: 2033-02-28→ Common Stock (200,000 underlying) - 400,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (400,000 underlying) - 400,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (400,000 underlying)
Footnotes (6)
- [F1]The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (33,600), and the remaining 83.2% of the target number has been forfeited (166,400).
- [F2]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
- [F3]The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period.
- [F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
- [F5]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
- [F6]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
Documents
Issuer
COMMUNITY HEALTH SYSTEMS INC
CIK 0001108109
Entity typeother
Related Parties
1- filerCIK 0001598637
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:06 PM ET
- Size
- 30.1 KB